Background Patients who develop cutaneous melanoma are at increased risk of developing a second primary melanoma. There are many aetiological reasons by which the risk of a second melanoma increases. Among others, genetic factors may contribute to modulating this risk. The risk of identifying a CDKN2A germline mutation increases with the number of primary melanomas and with the presence of familial history of melanoma. Patients with melanoma are especially encouraged to have regular follow-up visits with their dermatologist to perform clinical and dermatoscopic examination. In particular, dermoscopy could be very useful in multiple primary melanoma (MPM) patients. Objectives To analyse the clinical and dermatoscopic features of multiple me...
Background Worse outcomes have been noted in patients with multiple primary melanomas (MPMs) than in...
been linked to melanoma incidence in many families with multiple cases of the disease. Previous stud...
Cyclin-dependent kinase inhibitor type 2A (CDKN2A) has been identified as a major melanoma susceptib...
Background Patients who develop cutaneous melanoma are at increased risk of developing a second prim...
Germ-line mutations of CDKN2A have been identified as strong risk factors for melanoma in studies of...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
grantor: University of TorontoOnce a melanoma has reached the vertical growth phase the in...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
Background: About 10% of cutaneous malignant melanomas (CMM) occur in individuals with a family hist...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
CDKN2A is the most common, most penetrant gene whom germline mutations predisposing to cutaneous fam...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
Introduction: Multiple primary melanomas (MPM) occur up to 8% of patients with cutaneous malignant m...
Genetic susceptibility to primary cutaneous melanoma (PCM) may account for up to 12% of PCMs, presen...
Background Worse outcomes have been noted in patients with multiple primary melanomas (MPMs) than in...
been linked to melanoma incidence in many families with multiple cases of the disease. Previous stud...
Cyclin-dependent kinase inhibitor type 2A (CDKN2A) has been identified as a major melanoma susceptib...
Background Patients who develop cutaneous melanoma are at increased risk of developing a second prim...
Germ-line mutations of CDKN2A have been identified as strong risk factors for melanoma in studies of...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
grantor: University of TorontoOnce a melanoma has reached the vertical growth phase the in...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
Background: About 10% of cutaneous malignant melanomas (CMM) occur in individuals with a family hist...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
CDKN2A is the most common, most penetrant gene whom germline mutations predisposing to cutaneous fam...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
Introduction: Multiple primary melanomas (MPM) occur up to 8% of patients with cutaneous malignant m...
Genetic susceptibility to primary cutaneous melanoma (PCM) may account for up to 12% of PCMs, presen...
Background Worse outcomes have been noted in patients with multiple primary melanomas (MPMs) than in...
been linked to melanoma incidence in many families with multiple cases of the disease. Previous stud...
Cyclin-dependent kinase inhibitor type 2A (CDKN2A) has been identified as a major melanoma susceptib...